STOCKSCREENR

DGX

NYSE

Quest Diagnostics Incorporated

$194.20+4.88(+2.58%)Mkt Cap: $21.50B

Key Stats

Market Cap

$21.50B

P/E Ratio

21.48

EPS

$9.04

Dividend Yield

1.66%

52-Week Range

$164.65 — $213.50

Volume

770.41K

Avg Volume

1.01M

Beta

0.65

Price Alerts for DGX

Get alerted when DGX hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

21.48

Forward P/E

18.26

PEG Ratio

1.46

P/S (TTM)

1.93

P/B (TTM)

2.93

P/FCF

50.94

EV/EBITDA

49.90x

EV/Sales

—

Financial Health

ROE (TTM)

0.14%

ROA (TTM)

0.06%

ROIC

0.03%

Gross Margin

0.33%

Operating Margin

0.14%

Net Margin

0.09%

Debt/Equity

0.95

Current Ratio

1.18

Growth

EPS Growth (YoY)

+0.08%

Revenue Growth (YoY)

+0.13%

EPS Growth (3Y)

+0.03%

EPS Growth (5Y)

+0.02%

Sales Growth (3Y)

+0.04%

Sales Growth (5Y)

+0.04%

EPS Est (This Year)

$10.63

EPS Est (Next Year)

$11.47

Dividends

Dividend Yield

—

Annual Dividend

$0.80

Payout Ratio

0.36%

Frequency

—

Ex-Dividend Date

2026-01-13

Cash/Share

$3.57

Analyst Consensus

2.0

Buy

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$200.00$214.50$235.00
LowMedianHigh

Consensus Target: $215.10(10.8% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

111.24M

Float

110.73M

Free Float %

99.54%

Technicals

RSI (14)

77.66

SMA 20

$188.42

SMA 50

$182.50

SMA 200

$180.45

ATR (14)

4.74

Volatility (Week)

0.03%

Volatility (Month)

0.02%

Pattern

—

Performance

1 Day

+0.94%

1 Week

+9.54%

1 Month

+17.82%

3 Months

+12.47%

6 Months

+16.01%

1 Year

—

YTD

+19.28%

All-Time High

$208.34

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

NYSE

IPO Date

1996-12-17

Employees

55000

CEO

James E. Davis

Index Membership

S&P 500

Website

https://www.questdiagnostics.com

Quest Diagnostics Incorporated (DGX) is a healthcare company in the medical - diagnostics & research industry listed on the NYSE. With a market capitalization of $21.50B, a P/E ratio of 21.48, and a dividend yield of 1.66%, DGX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare DGX against other stocks using dozens of fundamental and technical filters.

Similar Stocks

LH

Labcorp Holdings Inc.

$256.80

-0.13%

$21.16B

A

Agilent Technologies, Inc.

$115.55

+3.82%

$32.65B

IQV

IQVIA Holdings Inc.

$158.37

+1.09%

$26.88B

MTD

Mettler-Toledo International Inc.

$1276.61

+2.94%

$25.95B

IDXX

IDEXX Laboratories, Inc.

$560.80

+1.29%

$44.65B

WAT

Waters Corporation

$309.23

+5.85%

$18.40B

Frequently Asked Questions

What is Quest Diagnostics Incorporated's P/E ratio?

Quest Diagnostics Incorporated (DGX) has a trailing twelve-month (TTM) P/E ratio of 21.48. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Quest Diagnostics Incorporated pay a dividend?

No, Quest Diagnostics Incorporated (DGX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Quest Diagnostics Incorporated's market cap?

Quest Diagnostics Incorporated (DGX) has a market capitalization of $21.50 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about DGX?

Wall Street analysts have a consensus "Buy" rating on Quest Diagnostics Incorporated (DGX) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $215.10 implies 10.8% upside from the current price.

How has DGX performed this year?

Quest Diagnostics Incorporated (DGX) has returned +19.28% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.